RxDoctor Payments Data

Henry Ficke, DPM

Podiatrist · Brooklyn, NYNPI 1679565329

Payments from drug & device makers

$272in general payments, 2019–2025

Across 7 payments — averaging $38.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$189
  • IBSA Pharma Inc.$43
  • Phadia US Inc.$24
  • Arbor Pharmaceuticals, Inc.$17

What the payments were for

  • Food & beverage$272100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)3$189
IBSA Pharma Inc.2$43
Phadia US Inc.1$24
Arbor Pharmaceuticals, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$272 in reported general payments places this provider in the 35th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$392,802
Medicare patients
774
Services billed
4,524

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JubliaEfinaconazole38$51,095
Diclofenac Sodium198$30,057
Clotrimazole740$21,829
Budesonide ErBudesonide16$15,148
Tavaborole11$15,022
Ketoconazole426$13,311
Ammonium Lactate530$8,560
Ciclopirox40$2,868
Caspofungin Acetate19$2,613
Clindamycin Phosphate45$2,320
Mupirocin413$2,167
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip98$1,281
Lidocaine18$1,251
Lidocaine Hcl ViscousLidocaine Hcl13$804
Silver Sulfadiazine34$774

Paid to pharmacies, not to this prescriber.

Other podiatrist in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →